Repository logo
 
Publication

Regulation of histone H2A.Z expression is mediated by sirtuin 1 in prostate cancer

dc.contributor.authorBaptista, Tiago
dc.contributor.authorPinho dos Santos Graça, Maria Inês
dc.contributor.authorSousa, Elsa Joana
dc.contributor.authorOliveira, Ana Isabel
dc.contributor.authorCosta, Natália R.
dc.contributor.authorCosta-Pinheiro, Pedro
dc.contributor.authorAmado, Francisco
dc.contributor.authorHenrique, Rui
dc.contributor.authorJerónimo, Carmen
dc.date.accessioned2014-02-03T10:54:33Z
dc.date.available2014-02-03T10:54:33Z
dc.date.issued2013
dc.description.abstractHistone variants seem to play a major role in gene expression regulation. In prostate cancer, H2A.Z and its acetylated form are implicated in oncogenes’ upregulation. SIRT1, which may act either as tumor suppressor or oncogene, reduces H2A.Z levels in cardiomyocytes, via proteasome-mediated degradation, and this mechanism might be impaired in prostate cancer cells due to sirtuin 1 downregulation. Thus, we aimed to characterize the mechanisms underlying H2A.Z and SIRT1 deregulation in prostate carcinogenesis and how they interact. We found that H2AFZ and SIRT1 were up- and downregulated, respectively, at transcript level in primary prostate cancer and high-grade prostatic intraepithelial neoplasia compared to normal prostatic tissues. Induced SIRT1 overexpression in prostate cancer cell lines resulted in almost complete absence of H2A.Z. Inhibition of mTOR had a modest effect on H2A.Z levels, but proteasome inhibition prevented the marked reduction of H2A.Z due to sirtuin 1 overexpression. Prostate cancer cells exposed to epigenetic modifying drugs trichostatin A, alone or combined with 5-aza-2’-deoxycytidine, increased H2AFZ transcript, although with a concomitant decrease in protein levels. Conversely, SIRT1 transcript and protein levels increased after exposure. ChIP revealed an increase of activation marks within the TSS region for both genes. Remarkably, inhibition of sirtuin 1 with nicotinamide, increased H2A.Z levels, whereas activation of sirtuin 1 by resveratrol led to an abrupt decrease in H2A.Z. Finally, protein-ligation assay showed that exposure to epigenetic modifying drugs fostered the interaction between sirtuin 1 and H2A.Z. We concluded that sirtuin 1 and H2A.Z deregulation in prostate cancer are reciprocally related. Epigenetic mechanisms, mostly histone post-translational modifications, are likely involved and impair sirtuin 1-mediated downregulation of H2A.Z via proteasome-mediated degradation. Epigenetic modifying drugs in conjunction with enzymatic modulators are able to restore the normal functions of sirtuin 1 and might constitute relevant tools for targeted therapy of prostate cancer patientspor
dc.identifier.citationBaptista, T., Graça, I., Sousa, E. J., Oliveira, A. I., Costa, N. R., Costa-Pinheiro, P., Amado, F., Henrique, R., & Jeronimo, C. (2013). Regulation of histone H2A.Z expression is mediated by sirtuin 1 in prostate cancer. Oncotarget, 4(10), 1673–1685. https://doi.org/10.18632/oncotarget.1237
dc.identifier.doi10.18632/oncotarget.1237pt_PT
dc.identifier.issn1949-2553
dc.identifier.urihttp://hdl.handle.net/10400.22/3594
dc.language.isoengpor
dc.peerreviewedyespor
dc.publisherImpact Journalspor
dc.relation.ispartofseriesOncotarget; Vol. 4, Nº 10
dc.relation.publisherversionhttp://www.impactjournals.com/oncotarget/index.php?journal=oncotarget&page=article&op=view&path[]=1237
dc.subjectProstate cancerpor
dc.subjectH2A.Zpor
dc.subjectSirtuin 1
dc.subjectEpigenetic drugs
dc.titleRegulation of histone H2A.Z expression is mediated by sirtuin 1 in prostate cancerpor
dc.typejournal article
dspace.entity.typePublication
oaire.citation.endPage1685por
oaire.citation.issueNº 10
oaire.citation.startPage1673por
oaire.citation.titleOncotarget
oaire.citation.volumeVol. 4por
person.familyNamePinho dos Santos Graça
person.familyNameOliveira
person.givenNameMaria Inês
person.givenNameAna Isabel
person.identifier.orcid0000-0003-1383-4242
person.identifier.orcid0000-0002-3160-6596
person.identifier.scopus-author-id6505981373
rcaap.rightsopenAccesspor
rcaap.typearticlepor
relation.isAuthorOfPublication8316e6ce-cc0a-41e6-90ab-910c93868670
relation.isAuthorOfPublicationb38c382c-5355-4b8e-aae0-45af3aa1dc8e
relation.isAuthorOfPublication.latestForDiscovery8316e6ce-cc0a-41e6-90ab-910c93868670

Files

Original bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
ART_TiagoBaptista_2013.pdf
Size:
3.6 MB
Format:
Adobe Portable Document Format
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description: